Koyfin Home > Directory > Health Care > Acceleron Pharma > Preferred Equity

Acceleron Pharma Preferred Equity Chart (XLRN)

Acceleron Pharma annual/quarterly Preferred Equity from 2012 to 2013.
  • Acceleron Pharma Preferred Equity for the quarter ending March 03, 2013 was $274m
  • Acceleron Pharma Preferred Equity for the last 12 months ending March 03, 2013 was $274m
  • Acceleron Pharma Annual Preferred Equity for 2012 was $270m a 10.16% increase of 27m from 2011
  • Acceleron Pharma Annual Preferred Equity for 2011 was $243m
Other Balance Sheet Metrics:
  • Acceleron Pharma Total Assets for the quarter ending September 09, 2018 was $338m a -15.10% decrease of -51m year over year
  • Acceleron Pharma Other Liabilities for the quarter ending December 12, 2018 was $4m a 14.46% increase of 1m year over year
  • Acceleron Pharma Total Equity for the quarter ending September 09, 2018 was $319m a -14.45% decrease of -46m year over year
View Chart On Koyfin

Quarterly XLRN Preferred Equity Data

03/2013$274m
12/2012$270m
03/2012$243m

Annual XLRN Preferred Equity Data

2012$270m
2011$243m